Autolus Therapeutics

NASDAQ: AUTL · Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT

Autolus Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-238.13M -220.66M -270.23M -233.98M -221.26M -208.38M -158.16M -155.08M -151.59M -148.84M -163.55M -154.78M -145.89M -142.1M -143.29M -146.62M -145.49M
Depreciation & Amortization
8.19M 7.72M 7.41M 6.86M 6.47M 6.57M 6.44M 6.85M 7.25M 7.42M 7.88M 8.54M 8.86M 8.46M 8.02M 7.04M 6.06M
Stock-Based Compensation
16.05M 15.47M 12.51M 11.35M 11.08M 11.2M 11.34M 11.82M 12.08M 12.01M 16.42M 14.59M 12.95M 9.94M 6.35M 9.09M 13.25M
Other Working Capital
-5.3M -25.25M -516K -8.7M -1.97M 801K -11.15M -6.15M -4.63M 3.95M 16.39M 12.91M 5.89M 4.14M -8.63M -9.81M -4.05M
Other Non-Cash Items
-364K 19.62M 62.33M 76.08M 66.57M 45.72M 16.23M 12.04M 17.41M 13.39M 17.05M 9.93M 8.65M 7.54M 6.13M 4.79M -2M
Deferred Income Tax
534K -185K -792K -862K -1.02M -986K -201K -123K -289K -268K -1.01M -614K 34K -72K -996K -1.23M -1.62M
Change in Working Capital
-27.6M -23.66M 165K -11.49M -937K 292K -10.97M -2.54M -4.57M 3.97M 16.31M 12.59M 5.62M 4.14M -7.19M -8.38M -2.61M
Operating Cash Flow
-241.32M -206.27M -193.17M -156.62M -143.68M -145.59M -135.32M -127.04M -119.7M -112.31M -106.9M -109.75M -115.55M -117.86M -136.43M -140.75M -131.07M
Capital Expenditures
-42.53M -34.82M -12.44M -4.35M -7.9M -10.99M -10.14M -15.44M -13.69M -10.84M -11.79M -8.86M -7.73M -8.86M -12.74M -12.93M -13.94M
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
-71.3M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
20M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
-372.48M -372.48M -10.99M -10.99M -10.99M -10.99M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
-453.57M -394.55M -12.44M -4.35M -7.9M -10.99M -10.14M -15.44M -13.69M -10.84M -11.79M -8.86M -7.73M -8.86M -12.74M -12.93M -13.94M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -297K
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
28.11M 39.58M 9.59M 9.41M 11.27M -883K 58.75M 58.85M 59.07M 59.76M 147.52M 147.41M 141.43M 10.54M -136.88M -136.87M -130.89M
Financial Cash Flow
28.11M 589.55M 559.57M 559.39M 561.25M -883K 222.6M 222.7M 222.92M 223.61M 147.52M 147.18M 160.74M 284.06M 137.04M 137.28M 123.43M
Net Cash Flow
-662.29M -11.53M 400.92M 398.36M 415.42M -143.19M 93.48M 91.07M 74.46M 72.08M -9.9M 200K 29.09M 156.59M -5.21M 3.73M -4.3M
Free Cash Flow
-283.85M -241.09M -205.61M -160.97M -151.58M -156.57M -145.46M -142.48M -133.39M -123.15M -118.69M -118.6M -123.28M -126.72M -149.18M -153.68M -145.01M